Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical neuroprotective therapy to prevent or arrest diabetic retinopathy
2012-001200-38Phase 2Completed
- Sponsor
- BCN Peptides
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in diabetic retinopathy (DR) comparing Topical somatostatin with Topical brimonidine (2 arms). Primary endpoint: Implicit time in mfERG (IT-mfERG). Started Sep 2012; status: completed.
02
Drugs
somatostatinbrimonidine
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on 2012-001200-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001200-38.